Quanome Technologies, Inc. QNME
0.74
(0.07)
(8.64%)
as of 25 Sep
- Market cap
- $26.9M
- P/E
- 0.0×
Follow QNME
| Older periods | Jun '25 | Sep '25 | Dec '25 | Mar '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(301.02%) | (99.65%) | (70.96%) | (51.41%) | |
| (44.46%) | (35.78%) | (28.74%) | (26.63%) | ||
ROIC |
0.00% | (106.40%) | (25.14%) | (28.34%) | |
Return on Tangible Assets |
(678.32%) | (94.66%) | (44.01%) | (27.85%) | |
Average Days of Receivables |
33.42 | 175.77 | 189.49 | 110.27 | |
Free Cash Flow per Share |
(0.43) | (0.36) | (0.27) | (0.14) | |
Free Cash Flow |
(3.26) | (5.27) | (5.19) | (4.72) | |
Capital Expenditures |
(0.60) | — | — | — | |
Piotroski F-Score |
2.00 | 1.00 | 4.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
(30.09%) | (44.06%) | (36.53%) | (31.35%) | |
Accounts Receivable Turnover |
7.24 | 3.32 | 3.33 | 5.31 | |
Accounts Payable Turnover |
12.39 | 9.41 | 8.09 | 13.74 | |
Inventory Turnover |
0.00 | 0.00 | 264.62 | 151.26 | |
Average Days of Payables |
24.92 | 59.05 | 63.53 | 19.83 | |
Days of Inventory on Hand |
2.36 | 2.95 | 2.55 | 0.45 | |
Tax Rate |
0.02 | 0.07 | 0.06 | 0.05 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
43.87% | 41.72% | 40.52% | 46.20% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.51 | 1.00 | 1.06 | 1.28 | |
Depreciation/Fixed assets |
2.64 | 1.29 | 1.79 | 2.96 | |
Capex/Depreciation |
(1.42) | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
2.35 | 1.34 | 1.19 | 0.70 | |
Operating CF per Share |
(0.35) | (0.36) | (0.27) | (0.14) | |
Capex per Share |
(0.08) | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.03 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(29.49%) | (26.59%) | (21.12%) | (15.35%) |
Columns are period end dates